Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 27 June 2016 |
| Author/s |
author: Wu-Chou Su Giorgio Scagliotti |
| Publication date | June 27, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |